According to MarketsandMarkets™, the Genomic Biomarkers Market is projected to grow from about USD 29.00 billion in 2025 to ...

According to MarketsandMarkets, the Genomic Biomarkers Market is projected to grow from about USD 29.00 billion in 2025 to USD 50.31 billion ...

The global companion diagnostics market is projected to grow at a robust CAGR of approximately 13% through 2031. This growth is driven by the increasing demand for personalized medicine, continuous ...

DNA analysis of cultural artifacts shows diverse biological profiles, but contamination and mixed signals complicate historical lineage interpretation.

Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last ...

A streamlined, automated process helps scientists coordinate site-ready production-level whole genome sequencing results.

India's hospital chains, diagnostics networks, and global investors have poured millions of dollars into gene sequencing, ...

Myriad Genetics, Inc. MYGN is well-poised to grow in the coming quarters due to its impressive cadence of product launches. The company is also progressing well in its refreshed long-term strategy to ...

The pharmacogenomics landscape is evolving from a niche scientific pursuit to a cornerstone of value-based healthcare,” said ...

Advancements in next-generation sequencing technologies, increasing adoption of precision oncology, and rising cancer incidence worldwide are driving the genomics in cancer care market growth.Austin, ...

Oncology companion diagnostic market size was valued at USD 5.68 billion in 2025 and is projected to hit the market valuation of USD 12.84 billion by 2035 at a CAGR of 8.50% during the forecast period ...